Axsome Therapeutics AXSM Business Segments
| TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | TTM Q3 '24 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Royalty | $4.76M+28.1% | $3.71M+13.3% | $3.28M+6.6% | $3.08M-8.4% | $3.36M+12.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Axsome Therapeutics break its business down?
- Axsome Therapeutics (AXSM) reports revenue by product across 3 parts — Milestone Revenue, Royalty And Milestone Revenue and Royalty. Each is extracted from the segment footnotes and tracked over time.
- Where does Axsome Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Axsome Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
